Characterization of Sequence-Specific Binding of LARP6 to the 5' Stem-Loop of Type I Collagen mRNAs and Implications for Rational Design of Antifibrotic Drugs

J Mol Biol. 2022 Jan 30;434(2):167394. doi: 10.1016/j.jmb.2021.167394. Epub 2021 Dec 8.

Abstract

Excessive synthesis of type I collagen is a hallmark of fibrotic diseases. Binding of La-related protein 6 (LARP6) to the 5' stem-loop (5'SL) of collagen mRNAs regulates their translation leading to an unnaturally elevated rate of collagen biosynthesis in fibrosis. Previous work suggested that LARP6 needs two domains to form stable complex with 5'SL RNA, the La domain and the juxtaposed RNA recognition motif (RRM), jointly called the La-module. Here we describe that La domain of LARP6 is necessary and sufficient for recognition of 5'SL in RNA sequence specific manner. A three-amino-acid motif located in the flexible loop connecting the second α-helix to the β-sheet of the La domain, called the RNK-motif, is critical for binding. Mutation of any of these three amino acids abolishes the binding of the La domain to 5'SL. The major site of crosslinking of LARP6 to 5'SL RNA was mapped to this motif, as well. The RNK-motif is not found in other LARPs, which cannot bind 5'SL. Presence of RRM increases the stability of complex between La domain and 5'SL RNA and RRM domain does not make extensive contacts with 5'SL RNA. We propose a model in which the initial recognition of 5'SL by LARP6 is mediated by the RNK epitope and further stabilized by the RRM domain. This discovery suggests that the interaction between LARP6 and collagen mRNAs can be blocked by small molecules that target the RNK epitope and will help rational design of the LARP6 binding inhibitors as specific antifibrotic drugs.

Keywords: La-domain; La-related protein 6; RNA/protein recognition; binding affinity; fibrosis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Motifs
  • Autoantigens / chemistry*
  • Autoantigens / genetics
  • Autoantigens / metabolism
  • Collagen
  • Collagen Type I / biosynthesis
  • Collagen Type I / chemistry*
  • Fibrosis / metabolism*
  • Humans
  • Nucleic Acid Conformation
  • Pharmaceutical Preparations
  • Protein Binding
  • Protein Domains
  • RNA, Messenger / chemistry*
  • RNA, Messenger / metabolism
  • Ribonucleoproteins / chemistry*
  • Ribonucleoproteins / genetics
  • Ribonucleoproteins / metabolism
  • SS-B Antigen

Substances

  • Autoantigens
  • Collagen Type I
  • Pharmaceutical Preparations
  • RNA, Messenger
  • Ribonucleoproteins
  • Collagen